Article
BNIP3 as a potential biomarker for the identification of prognosis and diagnosis in solid tumours
30 Aug 2023
Abstract excerpt
BACKGROUND: Traditional radiotherapy and chemotherapy have been intensively studied for their role in the treatment of tumours. However, these therapies often cause side effects for patients, which calls for the development of novel treatment options for tumours. B-cell lymphoma-2 (Bcl-2)/adenovirus E1B 19 kDa-interacting protein 3 (BNIP3) reportedly apoptosis-inducing effects in tumour cells and is associated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
